Home » Topics » Dermatologic, BioWorld Science

Dermatologic, BioWorld Science
RSS

Gliatech reports promising pilot clinical trial results with ADCON-P

Sep. 29, 1998

Fujisawa concludes agreement for development of calcipotriol

Sep. 28, 1998

Topical SDZ-ASM-981 is effective in treating atopic dermatitis

Sep. 28, 1998

Vanguard discontinues development of psoriasis drugs

Sep. 25, 1998

Novel use for a known antidepressant: doxepin relieves pruritus in patients with eczema

Sep. 18, 1998

FDA accepts Dusa's NDA for filing

Sep. 15, 1998

AEterna releases interim phase I/II data for Psovascar

Sep. 14, 1998

Immune Response presents phase II data on psoriasis treatment

Sep. 11, 1998

RXR/RAR receptor modulators claimed by CIRD Galderma for skin and other disorders

Sep. 9, 1998

Biotech Australia announces encouraging early clinical trial results with leg ulcer treatment

Sep. 4, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 30, 2025.
Today's news in brief
Briefs
BioWorld MedTech briefs for Jan. 30, 2026.
Centessa’s CNT-9982 shows promise for MDD
BioWorld Science
Orexin OX2 receptor agonists have demonstrated the ability to enhance wakefulness in rodent models, as well as in nonhuman primates and patients with narcolepsy...
First-in-class ADC targeting DEM-TXX shows high preclinical efficacy
BioWorld Science
Researchers at DEM Biopharma Inc. reported preclinical findings demonstrating the efficacy of DEM-301, a bifunctional antibody-drug conjugate (ADC) engineered to...
5-HT2R allosteric ligands attenuate cocaine use and seeking behavior
BioWorld Science
Serotonergic G-protein-coupled receptors (GPCRs), including the 5-HT2A receptor (5-HT2AR) and 5-HT2CR, are key regulators of cortical signaling pathways and...